Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$2.49 - $20.59 $292,099 - $2.42 Million
117,309 Added 47.75%
363,008 $980,000
Q1 2023

May 11, 2023

SELL
$15.95 - $25.18 $220,668 - $348,365
-13,835 Reduced 5.33%
245,699 $4.58 Million
Q4 2022

Feb 13, 2023

BUY
$13.27 - $17.73 $420,619 - $561,987
31,697 Added 13.91%
259,534 $4.16 Million
Q3 2022

Nov 14, 2022

BUY
$11.4 - $14.6 $862,524 - $1.1 Million
75,660 Added 49.72%
227,837 $2.96 Million
Q2 2022

Aug 12, 2022

SELL
$7.94 - $12.96 $992,388 - $1.62 Million
-124,986 Reduced 45.09%
152,177 $1.61 Million
Q1 2022

May 13, 2022

BUY
$12.02 - $16.79 $75,040 - $104,819
6,243 Added 2.3%
277,163 $3.33 Million
Q4 2021

Feb 10, 2022

SELL
$9.93 - $15.39 $38,458 - $59,605
-3,873 Reduced 1.41%
270,920 $3.82 Million
Q3 2021

Nov 10, 2021

BUY
$10.18 - $26.64 $1.78 Million - $4.65 Million
174,699 Added 174.53%
274,793 $2.81 Million
Q2 2021

Aug 10, 2021

BUY
$18.57 - $35.68 $98,755 - $189,746
5,318 Added 5.61%
100,094 $2.67 Million
Q1 2021

May 10, 2021

BUY
$31.0 - $55.72 $2.23 Million - $4.01 Million
72,045 Added 316.95%
94,776 $3.29 Million
Q4 2020

Feb 10, 2021

SELL
$37.09 - $48.97 $902,065 - $1.19 Million
-24,321 Reduced 51.69%
22,731 $843,000
Q3 2020

Nov 13, 2020

BUY
$40.47 - $45.5 $891,270 - $1 Million
22,023 Added 87.99%
47,052 $1.94 Million
Q2 2020

Aug 07, 2020

BUY
$32.57 - $42.83 $608,114 - $799,678
18,671 Added 293.66%
25,029 $1.01 Million
Q1 2020

May 15, 2020

SELL
$23.3 - $45.96 $1.11 Million - $2.19 Million
-47,713 Reduced 88.24%
6,358 $221,000
Q4 2019

Feb 10, 2020

SELL
$34.58 - $48.06 $2.44 Million - $3.39 Million
-70,544 Reduced 56.61%
54,071 $2.32 Million
Q3 2019

Nov 14, 2019

BUY
$36.98 - $48.45 $113,861 - $149,177
3,079 Added 2.53%
124,615 $4.61 Million
Q2 2019

Aug 09, 2019

BUY
$35.13 - $55.53 $1.09 Million - $1.73 Million
31,168 Added 34.49%
121,536 $5.49 Million
Q1 2019

May 15, 2019

BUY
$42.83 - $59.91 $3.87 Million - $5.41 Million
90,368 New
90,368 $4.91 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.